119th Congress
H.R. 10359
Priority for Pediatric Cures Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Gus M. Bilirakis(R-FL)
- Introduced
- Sep 14, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (6)
Original cosponsors (5)
- Jake Auchincloss (D-MA)
- Kat Cammack (R-FL)
- Kevin Mullin (D-CA)
- Nanette Diaz Barragán (D-CA)
- Thomas H. Kean, Jr. (R-NJ)
Added later (1)
- Josh Riley (D-NY) · Oct 1, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
Latest action(Sep 14, 2026): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Sep 14, 2026 · House
Referred to the House Committee on Energy and Commerce. - Sep 14, 2026
Introduced in House